These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 14694058)
1. Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab. Rojas-García R; Gallardo E; de Andrés I; de Luna N; Juarez C; Sánchez P; Illa I Neurology; 2003 Dec; 61(12):1814-6. PubMed ID: 14694058 [TBL] [Abstract][Full Text] [Related]
2. Chronic ataxic neuropathy with cold agglutinins: atypical phenotype and response to anti-CD20 antibodies. Siddiqui K; Cahalane E; Keogan M; Hardiman O Neurology; 2003 Nov; 61(9):1307-8. PubMed ID: 14610153 [No Abstract] [Full Text] [Related]
5. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
6. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Berentsen S; Tjønnfjord GE; Brudevold R; Gjertsen BT; Langholm R; Løkkevik E; Sørbø JH; Ulvestad E Br J Haematol; 2001 Oct; 115(1):79-83. PubMed ID: 11722415 [TBL] [Abstract][Full Text] [Related]
7. Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. Maurer MA; Rakocevic G; Leung CS; Quast I; Lukačišin M; Goebels N; Münz C; Wardemann H; Dalakas M; Lünemann JD J Clin Invest; 2012 Apr; 122(4):1393-402. PubMed ID: 22426210 [TBL] [Abstract][Full Text] [Related]
8. [Identification and characterization of a monoclonal IgM reacting with disialylated gangliosides recognizing the CANOMAD syndrome]. Boussaïd I; Bouhour F; Vial C; Caudie C Ann Biol Clin (Paris); 2011; 69(4):476-80. PubMed ID: 21896416 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222 [TBL] [Abstract][Full Text] [Related]
15. Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy. Stork AC; Jacobs BC; Tio-Gillen AP; Eurelings M; Jansen MD; van den Berg LH; Notermans NC; van der Pol WL J Neuroimmunol; 2014 Mar; 268(1-2):89-94. PubMed ID: 24529728 [TBL] [Abstract][Full Text] [Related]
16. Neurophysiological and clinical responses to rituximab in patients with anti-MAG polyneuropathy. Zara G; Zambello R; Ermani M Clin Neurophysiol; 2011 Dec; 122(12):2518-22. PubMed ID: 21680240 [TBL] [Abstract][Full Text] [Related]
17. [Cranial nerve palsies: ganglioside autoantibodies indicating an immunoneuropathy]. Banati M; Vachalova I; Vynogradova I; Heckmann JG Dtsch Med Wochenschr; 2015 Jul; 140(15):1154-7. PubMed ID: 26230068 [TBL] [Abstract][Full Text] [Related]